Skip to content

COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BM3R)

COPD MSA 3 Regions: Epidemiology and Risk Factors of COPD in Rural Environment (BPCO MSA 3Régions : épidémiologie et Facteurs de Risque de la BPCO en Milieu Rural)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03299907
Acronym
BM3R
Enrollment
5263
Registered
2017-10-03
Start date
2012-11-01
Completion date
2014-05-30
Last updated
2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

The agricultural environment presents a unique profile in terms of epidemiology of pulmonary diseases. Certainly due to persistent exposure to organic particles, the prevalence of COPD is higher in farmers than in the general population, despite less smoking. It is likely that the risk of COPD depends on several factors, such as the type of farm, local conditions and the region where the farm is located. It is important to diagnose COPD at an early stage in order to initiate appropriate therapy, and implement secondary prevention with a view to limiting deterioration of respiratory function and reducing complications. In this context, the aims of BM3R project were: (1) to study the epidemiology of COPD in a large representative sample of French farmers, in order to identify the types of farming, working conditions and regions that are associated with the presence of COPD; and (2) to develop a score to identify patients at risk and optimise diagnosis of COPD in the context of a screening programme.

Interventions

DIAGNOSTIC_TESTSpirometry

Sponsors

Mutualité sociale agricole
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* \> 40 years old and \< 75 years old * Affiliated to the MSA

Exclusion criteria

* COPD known

Design outcomes

Primary

MeasureTime frame
FEV1/FVCAt the inclusion time

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026